<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The objective of this study was to identify biologic parameters that were associated with either exceptionally good or poor outcome in childhood <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Among the children with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> who entered Children's <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Group trial 213, 498 patients without <z:e sem="disease" ids="C0013080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Down syndrome</z:e> or <z:hpo ids='HP_0004836'>acute promyelocytic leukemia</z:hpo> (APL) comprise the basis for this report </plain></SENT>
<SENT sid="2" pm="."><plain>Univariate comparisons of the proportion of patients attaining complete remission after induction (CR) indicate that, at diagnosis, male gender, <z:hpo ids='HP_0001873'>low platelet count</z:hpo> (&lt; or =20 000/microl), <z:hpo ids='HP_0002240'>hepatomegaly</z:hpo>, <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), French-American- British (FAB) category M5, high (&gt;15%) bone marrow (BM) blasts on day 14 of the first course of induction, and +8 are associated with lower CR rates, while abnormal 16 is associated with a higher CR rate </plain></SENT>
<SENT sid="3" pm="."><plain>Multivariate analysis suggests high platelet count at diagnosis (&gt;20 000/microl), absence of <z:hpo ids='HP_0002240'>hepatomegaly</z:hpo>, &lt; or =15% day 14 BM blast percentage, and abnormal 16 are independent prognostic factors associated with better CR </plain></SENT>
<SENT sid="4" pm="."><plain>Univariate analysis demonstrated a significant favorable relationship between platelet count at diagnosis (&gt;20 000/microl), absence of <z:hpo ids='HP_0002240'>hepatomegaly</z:hpo>, low percentage of BM blasts (&lt; or =15%), and abnormal 16 with overall survival </plain></SENT>
<SENT sid="5" pm="."><plain>Absence of <z:hpo ids='HP_0002240'>hepatomegaly</z:hpo>, &lt; or =15% day 14 BM blast percentage, and abnormal 16 were determined to be independent prognostic factors associated with better survival </plain></SENT>
</text></document>